The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia-Reference-Cited by-同舟云学术

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia

Published:2022-05 Issue: Volume:208 Page:108982
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Brown Jessica,Iacovelli Luisa^ORCID,Di Cicco Gabriele,Grayson Ben,Rimmer Lauren^ORCID,Fletcher Jennifer^ORCID,Neill Joanna C.,Wall Mark J.^ORCID,Ngomba Richard T.,Harte Michael

Funder

MRC

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference74 articles.

1. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat;Abdul-Monim;J. Psychopharmacol.,2007

2. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction;Abe;J. Biol. Chem.,1992

3. Dopamine, the antipsychotic molecule: a perspective on mechanisms underlying antipsychotic response variability;Amato;Neurosci. Biobehav. Rev.,2018

4. An mGlu5-positive allosteric modulator rescues the neuroplasticity deficits in a genetic model of NMDA receptor hypofunction in schizophrenia;Balu;Neuropsychopharmacology,2016

5. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update;Cadinu;Neuropharmacol. Psychedelics: New Doors, Altered Perceptions.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel pharmacological targets for GABAergic dysfunction in ADHD;Neuropharmacology;2024-05

2. Mechanism of electroconvulsive therapy in schizophrenia: a bioinformatics analysis study of RNA-seq data;Psychiatric Genetics;2024-03-04

3. Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications;Neural Regeneration Research;2023-07-07

4. Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172;Cells;2023-03-16

5. Clinical investigations of compounds targeting metabotropic glutamate receptors;Pharmacology Biochemistry and Behavior;2022-09